These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 37713821)

  • 1. Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma.
    Wu X; Wang S; Chen K
    Medicine (Baltimore); 2023 Sep; 102(37):e34876. PubMed ID: 37713821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Prognostic and Immune Analysis of Ferroptosis-Related Genes Identifies SLC7A11 as a Novel Prognostic Biomarker in Lung Adenocarcinoma.
    Qian L; Wang F; Lu SM; Miao HJ; He X; Feng J; Huang H; Shi RF; Zhang JG
    J Immunol Res; 2022; 2022():1951620. PubMed ID: 35509981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC7A11 inhibits ferroptosis and downregulates PD-L1 levels in lung adenocarcinoma.
    Huang Z; Chen X; Wang Y; Yuan J; Li J; Hang W; Meng H
    Front Immunol; 2024; 15():1372215. PubMed ID: 38655266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma.
    Mao S; Wang Y; Chao N; Zeng L; Zhang L
    Cell Oncol (Dordr); 2024 Oct; 47(5):1697-1713. PubMed ID: 38616208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0070440 promotes lung adenocarcinoma progression by SLC7A11-mediated-ferroptosis.
    Zhao Y; Cui Q; Shen J; Shen W; Weng Y
    Histol Histopathol; 2023 Dec; 38(12):1429-1441. PubMed ID: 36852950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.
    Gao X; Tang M; Tian S; Li J; Liu W
    Future Oncol; 2021 Apr; 17(12):1533-1544. PubMed ID: 33432837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma.
    Shan Q; Zhang C; Li Y; Li Q; Zhang Y; Li X; Shi J; Hu F
    Sci Rep; 2023 Oct; 13(1):18302. PubMed ID: 37880315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signature.
    Si Y; Zhao Z; Meng X; Zhao K
    Sci Rep; 2024 Oct; 14(1):23243. PubMed ID: 39369095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.
    Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X
    Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
    Zhou J; Wang X; Li Z; Jiang R
    FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.
    Miao H; Ren Q; Li H; Zeng M; Chen D; Xu C; Chen Y; Wen Z
    BMC Cancer; 2022 Mar; 22(1):225. PubMed ID: 35236309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Predictive Model Incorporating Ferroptosis-Related Gene Signatures for Overall Survival in Patients with Lung Adenocarcinoma.
    Wang Y; Pan Y; Wu J; Luo Y; Fang Z; Xu R; Teng W; Chen M; Li Y
    Med Sci Monit; 2022 Feb; 28():e934050. PubMed ID: 35102130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
    He J; Zhang W; Li F; Yu Y
    Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
    Guo L; Li X; Liu R; Chen Y; Ren C; Du S
    Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting SLC3A2 subunit of system X
    Ma L; Zhang X; Yu K; Xu X; Chen T; Shi Y; Wang Y; Qiu S; Guo S; Cui J; Miao Y; Tian X; Du L; Yu Y; Xia J; Wang J
    Free Radic Biol Med; 2021 May; 168():25-43. PubMed ID: 33785413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq.
    Zhang P; Liu J; Pei S; Wu D; Xie J; Liu J; Li J
    Front Immunol; 2023; 14():1189520. PubMed ID: 37256127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma.
    Huang L; Zhong L; Cheng R; Chang L; Qin M; Liang H; Liao Z
    Aging (Albany NY); 2023 Sep; 15(18):9676-9694. PubMed ID: 37728413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques.
    He D; Tang H; Yang X; Liu X; Zhang Y; Shi J
    Front Immunol; 2023; 14():1278496. PubMed ID: 37965333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the immune landscape and drug prediction of an M2 tumor-associated macrophage-related gene signature in EGFR-negative lung adenocarcinoma.
    Huang Y; Zhang Y; Duan X; Hou R; Wang Q; Shi J
    Thorac Cancer; 2024 Jul; 15(21):1626-1637. PubMed ID: 38886907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.